用于测量心力衰竭患者脆弱性的仪器:叙述性审查
Cristiana Vitale1,2, Ilaria Spoletini3, Walter Gianni4
1Department of Human Sciences and Promotion of Quality of Life San Raffaele Open, San Raffaele Open University of Rome, Rome, Italy. cristiana.vitale@gmail.com.
Current heart failure reports
|October 3, 2025
概括
评估心力衰竭 (HF) 患者的脆弱性对于预测结果至关重要. 本综述审查了当前的脆弱性评估工具,以指导临床决策并改善高频率患者的患者管理.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 临床医学 临床医学
背景情况:
- 虚弱是心力衰竭 (HF) 患者中普遍存在的多维综合征.
- 它与诸如降低生活质量,残疾,住院和死亡率等不良结果有显著的相关性.
研究的目的:
- 批判性地审查用于HF的临床实践中使用的既有脆弱性评估仪器.
- 为了比较这些工具的优势和局限性.
- 讨论HF脆弱性评估的预后价值.
主要方法:
- 这是一个叙事评论.
- 它综合了广泛使用的高频脆弱性评估工具的信息.
- 它讨论了两种主要方法:化表型和脆弱指数,以及新的心力衰竭脆弱性得分 (HFFS).
主要成果:
- 存在多种工具来评估HF的脆弱性,其复杂性和应用性各不相同.
- 弗里德表型和脆弱指数代表了两个主要的评估方法.
- 最近为心力衰竭患者推出了一种新的心力衰竭脆弱性评分 (HFFS).
结论:
- 虚弱是心力衰竭的一个关键预后因素.
- 系统的脆弱性评估对于指导治疗决策至关重要.
- 在易受伤害的HF患者中优化临床结果,需要进行常规的脆弱性评估.
相关概念视频
Heart Failure VII: Nursing Interventions
416
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
416
Heart Failure I: Introduction
693
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
693
Heart Failure III: Clinical Manifestations
485
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
485
Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722


